APA (7th ed.) Citation

R, Y., V, S., C, G., S, T., A, M., B, C., & LM, C. (2014). Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma. Cancer chemotherapy and pharmacology, 73(3), 639. https://doi.org/10.1007/s00280-014-2395-y

Chicago Style (17th ed.) Citation

R, Yung, Seyfoddin V, Guise C, Tijono S, McGregor A, Connor B, and Ching LM. "Efficacy Against Subcutaneous or Intracranial Murine GL261 Gliomas in Relation to the Concentration of the Vascular-disrupting Agent, 5,6-dimethylxanthenone-4-acetic Acid (DMXAA), in the Brain and Plasma." Cancer Chemotherapy and Pharmacology 73, no. 3 (2014): 639. https://doi.org/10.1007/s00280-014-2395-y.

MLA (9th ed.) Citation

R, Yung, et al. "Efficacy Against Subcutaneous or Intracranial Murine GL261 Gliomas in Relation to the Concentration of the Vascular-disrupting Agent, 5,6-dimethylxanthenone-4-acetic Acid (DMXAA), in the Brain and Plasma." Cancer Chemotherapy and Pharmacology, vol. 73, no. 3, 2014, p. 639, https://doi.org/10.1007/s00280-014-2395-y.